Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Long-Term Debt Repayments: 2012-2023

Historic Long-Term Debt Repayments for Ocular Therapeutix (OCUL) over the last 8 years, with Dec 2023 value amounting to $26.1 million.

  • Ocular Therapeutix's Long-Term Debt Repayments was N/A to $2.1 million in Q2 2021 from the same period last year, while for Jun 2021 it was $7.3 million, marking a year-over-year change of. This contributed to the annual value of $26.1 million for FY2023, which is N/A change from last year.
  • Latest data reveals that Ocular Therapeutix reported Long-Term Debt Repayments of $26.1 million as of FY2023, which was up 526.95% from $4.2 million recorded in FY2021.
  • Ocular Therapeutix's 5-year Long-Term Debt Repayments high stood at $26.1 million for FY2023, and its period low was $4.2 million during FY2021.
  • Its 2-year average for Long-Term Debt Repayments is $15.1 million, with a median of $15.1 million in 2021.